TE Witzig

588 total citations
8 papers, 451 citations indexed

About

TE Witzig is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, TE Witzig has authored 8 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in TE Witzig's work include Multiple Myeloma Research and Treatments (7 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Cancer Treatment and Pharmacology (2 papers). TE Witzig is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Cancer Treatment and Pharmacology (2 papers). TE Witzig collaborates with scholars based in United States. TE Witzig's co-authors include PR Greipp, MQ Lacy, Rafaël Fonseca, S. Vincent Rajkumar, RA Kyle, MA Gertz, MR Litzow, Angela Dispenzieri, Susan M. Geyer and G Dewald and has published in prestigious journals such as Blood, Leukemia and Bone Marrow Transplantation.

In The Last Decade

TE Witzig

8 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
TE Witzig United States 8 334 261 212 105 63 8 451
Rapp Mj France 6 246 0.7× 153 0.6× 184 0.9× 77 0.7× 104 1.7× 9 421
Luca De Rosa Italy 10 324 1.0× 226 0.9× 234 1.1× 37 0.4× 47 0.7× 31 448
Mark Juckett United States 11 264 0.8× 182 0.7× 161 0.8× 120 1.1× 116 1.8× 16 521
D Borrego Spain 7 342 1.0× 186 0.7× 155 0.7× 105 1.0× 47 0.7× 11 414
Τατιάνα Τζένου Greece 12 200 0.6× 179 0.7× 123 0.6× 145 1.4× 128 2.0× 26 394
Fernando Escalante Spain 10 236 0.7× 171 0.7× 120 0.6× 84 0.8× 41 0.7× 36 325
Nuria Quintana Spain 6 446 1.3× 382 1.5× 276 1.3× 163 1.6× 89 1.4× 7 646
JM Hernández Spain 8 346 1.0× 187 0.7× 115 0.5× 100 1.0× 54 0.9× 12 426
Connie Qi Canada 8 269 0.8× 236 0.9× 137 0.6× 76 0.7× 56 0.9× 14 350
Philip R. Greipp United States 7 201 0.6× 163 0.6× 117 0.6× 85 0.8× 40 0.6× 8 324

Countries citing papers authored by TE Witzig

Since Specialization
Citations

This map shows the geographic impact of TE Witzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by TE Witzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites TE Witzig more than expected).

Fields of papers citing papers by TE Witzig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by TE Witzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by TE Witzig. The network helps show where TE Witzig may publish in the future.

Co-authorship network of co-authors of TE Witzig

This figure shows the co-authorship network connecting the top 25 collaborators of TE Witzig. A scholar is included among the top collaborators of TE Witzig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with TE Witzig. TE Witzig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ansell, S., et al.. (2002). Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells. Leukemia. 16(10). 2142–2147. 46 indexed citations
2.
Rajkumar, S. Vincent, Angela Dispenzieri, Rafaël Fonseca, et al.. (2001). Thalidomide for previously untreated indolent or smoldering multiple myeloma. Leukemia. 15(8). 1274–1276. 134 indexed citations
3.
Gertz, MA, MQ Lacy, DJ Inwards, et al.. (2000). Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma. Bone Marrow Transplantation. 26(1). 45–50. 30 indexed citations
4.
Rajkumar, S. Vincent, Rafaël Fonseca, Angela Dispenzieri, et al.. (2000). Effect of complete response on outcome following autologous stem cell transplantation for myeloma. Bone Marrow Transplantation. 26(9). 979–983. 50 indexed citations
5.
Rajkumar, S. Vincent, Rafaël Fonseca, MQ Lacy, et al.. (1999). Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma. Bone Marrow Transplantation. 24(5). 497–503. 40 indexed citations
6.
Rajkumar, S. Vincent, Rafaël Fonseca, MQ Lacy, et al.. (1999). Autologous stem cell transplantation for relapsed and primary refractory myeloma. Bone Marrow Transplantation. 23(12). 1267–1272. 51 indexed citations
7.
Lacy, MQ, DJ Inwards, PR Greipp, et al.. (1999). Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma. Bone Marrow Transplantation. 23(3). 221–226. 26 indexed citations
8.
Hoyer, J. D., et al.. (1995). True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases [see comments]. Blood. 86(3). 1163–1169. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026